Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 01, 2022

BUY
$40.85 - $77.67 $862,711 - $1.64 Million
21,119 Added 4.67%
473,681 $20.8 Million
Q1 2022

May 04, 2022

BUY
$59.95 - $92.06 $4.92 Million - $7.55 Million
82,039 Added 22.14%
452,562 $32.7 Million
Q4 2021

Feb 07, 2022

SELL
$81.07 - $121.29 $235,021 - $351,619
-2,899 Reduced 0.78%
370,523 $30 Million
Q3 2021

Nov 02, 2021

SELL
$101.99 - $166.36 $4.05 Million - $6.6 Million
-39,695 Reduced 9.61%
373,422 $43.5 Million
Q2 2021

Aug 03, 2021

BUY
$141.6 - $179.06 $2.16 Million - $2.74 Million
15,289 Added 3.84%
413,117 $68.5 Million
Q1 2021

May 04, 2021

SELL
$132.81 - $182.18 $3.23 Million - $4.44 Million
-24,354 Reduced 5.77%
397,828 $55.5 Million
Q4 2020

Feb 01, 2021

SELL
$138.17 - $184.34 $1.94 Million - $2.59 Million
-14,071 Reduced 3.23%
422,182 $73.1 Million
Q3 2020

Nov 09, 2020

BUY
$114.09 - $145.51 $3.5 Million - $4.46 Million
30,664 Added 7.56%
436,253 $60.8 Million
Q2 2020

Aug 07, 2020

BUY
$89.45 - $129.85 $207,255 - $300,862
2,317 Added 0.57%
405,589 $48.5 Million
Q1 2020

May 04, 2020

BUY
$70.23 - $144.31 $564,719 - $1.16 Million
8,041 Added 2.03%
403,272 $40.3 Million
Q4 2019

Feb 06, 2020

SELL
$76.41 - $117.54 $359,661 - $553,260
-4,707 Reduced 1.18%
395,231 $46.5 Million
Q4 2019

Feb 04, 2020

BUY
$76.41 - $117.54 $30.2 Million - $46.4 Million
395,101 Added 8168.31%
399,938 $53.2 Million
Q3 2019

Nov 12, 2019

BUY
$61.52 - $91.1 $297,572 - $440,650
4,837 New
4,837 $416,000
Q2 2018

Aug 02, 2018

SELL
$72.38 - $92.5 $169,731 - $216,912
-2,345 Closed
0 $0
Q1 2018

May 04, 2018

BUY
$69.46 - $88.57 $155,937 - $198,839
2,245 Added 2245.0%
2,345 $203,000
Q4 2017

Feb 01, 2018

BUY
$65.94 - $93.31 $6,594 - $9,331
100
100 $7,000

Others Institutions Holding NVRO

About NEVRO CORP


  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $133M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.